Here are the 424B prospectus supplements from Micropolis AI Robotics (MCRP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow MCRP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MCRP filings page.
Micropolis AI Robotics updates its prospectus supplement to reflect an amendment to a warrant held by Streeterville Capital, LLC. The registration statement continues to cover 7,100,000 ordinary shares for resale, comprising conversion shares and warrant shares; references to "Warrant Shares" now refer to up to 2,500,000 ordinary shares issuable upon exercise of the warrant, as amended.
The Prospectus Supplement confirms the company will not receive proceeds from sales by the selling shareholder; the company may receive proceeds only if the amended warrant is exercised for cash at the stated exercise price. The total registered amount is not increased.
Micropolis Holding Company is registering up to 7,100,000 Ordinary Shares for resale by Streeterville Capital, LLC. These consist of up to 5,000,000 shares issuable on exercise of a warrant at $5.00 per share and up to 2,100,000 shares issuable on conversion of a $5,430,000 promissory note at an initial $2.75 conversion price, both subject to adjustment. Micropolis will not receive any proceeds from Streeterville’s resale of these shares, and will receive cash only if the warrant is exercised for cash, which could yield up to about $25.0 million.
Issuances are limited by a 9.99% beneficial ownership cap and a 19.99% “Exchange Cap” absent shareholder approval or an applicable home-country exception, so the actual number of shares ultimately issued may differ from 7,100,000. The company is a pre-revenue, emerging growth, foreign private issuer focused on autonomous mobile robots in the UAE and Saudi Arabia, and its auditors have raised substantial doubt about its ability to continue as a going concern.